(S)-N-((3',5'-dichlorobiphenyl-4-yl)methyl)pyrrolidine-2-carboxamide

ID: ALA1092167

PubChem CID: 46884099

Max Phase: Preclinical

Molecular Formula: C18H18Cl2N2O

Molecular Weight: 349.26

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=C(NCc1ccc(-c2cc(Cl)cc(Cl)c2)cc1)[C@@H]1CCCN1

Standard InChI:  InChI=1S/C18H18Cl2N2O/c19-15-8-14(9-16(20)10-15)13-5-3-12(4-6-13)11-22-18(23)17-2-1-7-21-17/h3-6,8-10,17,21H,1-2,7,11H2,(H,22,23)/t17-/m0/s1

Standard InChI Key:  NIJDBDOHWSEGPP-KRWDZBQOSA-N

Molfile:  

     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
    5.0527   -8.6791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0516   -9.5065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7664   -9.9194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4828   -9.5060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4800   -8.6755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7646   -8.2664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1980   -9.9174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9118   -9.5038    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6269   -9.9152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3407   -9.5015    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6282  -10.7402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9661  -11.2264    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2223  -12.0106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0473  -12.0093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3009  -11.2243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3403   -8.2670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3414   -7.4409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6277   -7.0286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9123   -7.4413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9152   -8.2706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6295   -8.6791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6279   -6.2036    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.2023   -8.6858    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
 11 12  1  0
  5  6  2  0
  6  1  1  0
  1  2  2  0
  4  7  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 11  1  0
  3  4  2  0
  7  8  1  0
 16 17  2  0
 17 18  1  0
  8  9  1  0
 18 19  2  0
  4  5  1  0
 19 20  1  0
  9 10  2  0
 20 21  2  0
 21 16  1  0
  1 16  1  0
  2  3  1  0
 18 22  1  0
 11  9  1  6
 20 23  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA1092167

   (S)-N-((3'',5''-dichlorobiphenyl-4-yl)methyl)pyrrolidine-2-carboxamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 349.26

Molecular Weight (Monoisotopic): 348.0796

AlogP: 4.03

#Rotatable Bonds: 4

Polar Surface Area: 41.13

Molecular Species: BASE

HBA: 2

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 3

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 9.81

CX LogP: 3.90

CX LogD: 1.55

Aromatic Rings: 2

Heavy Atoms: 23

QED Weighted: 0.88

Np Likeness Score: -0.85

References

1. Liu KK, Lefker BA, Dombroski MA, Chiang P, Cornelius P, Patterson TA, Zeng Y, Santucci S, Tomlinson E, Gibbons CP, Marala R, Brown JA, Kong JX, Lee E, Werner W, Wenzel Z, Giragossian C, Chen H, Coffey SB..  (2010)  Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity.,  20  (7): [PMID:20202843] [10.1016/j.bmcl.2010.01.107]

Source

Source(1):

• Scientific Literature